Similar articles

• Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.

  Baum T, Rowles G, Shropshire AT, Gluckman MI. Baum T, et al. J Pharmacol Exp Ther. 1971 Feb;176(2):339-49. J Pharmacol Exp Ther. 1971. PMID: 4398186 No abstract available.
• Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.

  Levy JV. Levy JV. J Clin Pharmacol New Drugs. 1971 Jul-Aug;11(4):249-60. J Clin Pharmacol New Drugs. 1971. PMID: 4397374 No abstract available.
• Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).

  Somani P, Laddu AR. Somani P, et al. J Pharmacol Exp Ther. 1969 Nov;170(1):72-8. J Pharmacol Exp Ther. 1969. PMID: 4390814 No abstract available.
• Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.

  Somani P, Laddu AR, Hardm HF. Somani P, et al. J Pharmacol Exp Ther. 1970 Dec;175(3):577-92. J Pharmacol Exp Ther. 1970. PMID: 4395225 No abstract available.
• Perspectives in adrenergic beta-receptor blockade.

  Fitzgerald JD. Fitzgerald JD. Clin Pharmacol Ther. 1969 May-Jun;10(3):292-306. doi: 10.1002/cpt1969103292. Clin Pharmacol Ther. 1969. PMID: 4894830 Review. No abstract available.